Gabapentin dosage and effects
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin Dosage Guidelines and Effects in Humans
Gabapentin Dosage for Neuropathic Pain and Epilepsy
Gabapentin is widely used for neuropathic pain and as an antiepileptic drug. For chronic neuropathic pain in adults, effective doses typically range from 1200 mg to 3600 mg per day, with most studies using at least 1200 mg daily. About 3 to 4 out of 10 people experience significant pain relief at these doses, but more than half may not have meaningful benefit and could experience side effects such as dizziness, drowsiness, swelling, and gait disturbances. Serious adverse events are rare, and the medication is generally well tolerated, even at higher doses up to 3600 mg per day for epilepsy and pain management. Side effects are usually mild and transient, especially at the start of treatment or with rapid dose increases 24.
Gabapentin Dosage for Alcohol Use Disorder
Gabapentin has also been studied for alcohol dependence. In clinical trials, doses of 900 mg and 1800 mg per day have shown a dose-dependent improvement in abstinence rates and reduction in heavy drinking. Higher doses, such as 1800 mg and even up to 3600 mg per day, have been associated with greater reductions in alcohol consumption and improved mood, sleep, and craving, without serious adverse events. These findings suggest gabapentin is both effective and safe for treating alcohol use disorder at these dosages 36.
Gabapentin Dosage in Infants
In infants, gabapentin is used for neuropathic pain, irritability, and other conditions. Initial dosing often starts at 5 mg/kg per dose every 24 hours, with mean initiation doses around 8.6 mg/kg/day and maximum doses averaging 23.2 mg/kg/day, divided every 8 hours. Gabapentin was well tolerated in this population, with only minor adverse events reported. Improvements were seen in pain scores and weight gain, indicating both efficacy and safety in infants at these doses .
Gabapentin Dosage for Perioperative Pain
For perioperative pain control, especially in spine surgery, gabapentin doses of 900 mg per day have been found to provide the best pain relief and reduce opioid consumption, followed by 1200 mg, 600 mg, and 300 mg per day. No significant differences in adverse events were observed between these doses, suggesting that 900 mg per day is both effective and safe for short-term pain management in surgical settings .
Gabapentin Dosage and Effects in Animals
Dogs
Gabapentin is used in dogs for pain and behavioral disorders. Doses higher than 30 mg/kg are more likely to cause sedation, which is the most common side effect. However, most dogs tolerate gabapentin well, and side effects are generally mild. The effectiveness and side effects do not consistently correlate with specific dose ranges, indicating that individual sensitivity varies and dose adjustments may be necessary .
Horses
In horses, repeated administration of high doses (up to 120 mg/kg every 12 hours for 14 days) was well tolerated, with no significant changes in physical or biochemical parameters. This suggests gabapentin can be safely used at high doses in horses, though further research is needed to confirm its analgesic effects .
Other Animals
In cheetahs, single oral doses of 10 or 20 mg/kg produced mild sedation lasting up to 24 hours, with no significant difference between the two doses. In black-tailed prairie dogs, oral doses of 30 mg/kg maintained effective plasma concentrations for 12 hours, supporting twice-daily dosing for pain management 710.
Conclusion
Gabapentin is a versatile medication with a broad therapeutic index, used for pain, epilepsy, alcohol use disorder, and behavioral issues across humans and animals. Effective human doses for pain and alcohol use disorder typically range from 900 mg to 3600 mg per day, with good tolerability and mild, transient side effects. In infants and animals, dosing is weight-based and generally well tolerated, though individual responses may vary. Overall, gabapentin is considered safe and effective when dosed appropriately for the condition and patient population 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic